In ovarian cancer, a high level of ROS can reduce the uptake of tumor-derived exosomal miR-155-5p by macrophages, resulting in the upregulation of PD-L1 and subsequent suppression of CD8+ T cells (107). The gene discussed is CD8A; the disease is neoplasm.